Patent · US Active

Indolin-2-one or pyrrolo-pyridin/pyrimidin-2-one derivatives

US9616053B2 · kind B2 · utility

5Cited by

0References

7Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Daniela Brunner · The Bronx, US
Hans Hilpert · Reinach, CH
Sabine Kolczewski · Lörrach, DE
Anja Limberg · Penzberg, DE
Jessica Malberg · Dobbs Ferry, US
Eric Prinssen · Guebwiller, FR
Claus Riemer · Glückstadt, DE
Bavani Shankar · Tarrytown, US
Theodor Stoll · Basel, CH

Key dates

Filing date	Dec 16, 2015
Grant date	Apr 11, 2017
Priority date	—
Expiry date	Dec 16, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H19/044
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is concerned with 2-oxo-2,3-dihydro-indoles of general formula (I)wherein Ar, X, X1, R1, R2, R3, m, n and the dotted line are as defined herein which compounds are useful for treating certain central nervous system disorders as described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.